Wound care is one of the most significant, yet under-recognised challenges facing the UK’s health system. Estimated to cost the NHS upwards of £8.3 billion annually1 and accounting for around 50% of all community nurse activity,2 the burden is immense. Yet wound care rarely receives the attention afforded to other high-cost clinical areas like cancer, diabetes, or cardiovascular disease. It is time to change that, says the ABHI Wound Care Group.
Wound care is not only about dressings. It is a nurse-led, community-delivered, system-wide challenge that affects millions and is often a consequence of other long-term conditions. By improving wound care — particularly in areas such as lower limb wounds, pressure ulcers, and surgical wounds — the health system can release significant resource, improve patient experience, and address pressing issues of inequality. That is the mission of the ABHI Wound Care Group.
The ABHI Wound Care Group brings together multiple wound care manufacturers to represent the sector with one voice. The group works to raise the profile of tissue viability as a critical service and to demonstrate the vital role that technology and industry play in delivering better outcomes, enhancing patient experience, and achieving system efficiency.
Crucially, the group's objectives flex in response to the policy environment. Current priorities include engaging with the Department of Health and Social Care's (DHSC) Part IX review, promoting value-based procurement, ensuring access to innovation, and advocating for national recognition of wound care as a priority issue.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
